Cargando…

Characterization of PfTrxR inhibitors using antimalarial assays and in silico techniques

BACKGROUND: The compounds 1,4-napthoquinone (1,4-NQ), bis-(2,4-dinitrophenyl)sulfide (2,4-DNPS), 4-nitrobenzothiadiazole (4-NBT), 3-dimethylaminopropiophenone (3-DAP) and menadione (MD) were tested for antimalarial activity against both chloroquine (CQ)-sensitive (D6) and chloroquine (CQ)-resistant...

Descripción completa

Detalles Bibliográficos
Autores principales:	Munigunti, Ranjith, Gathiaka, Symon, Acevedo, Orlando, Sahu, Rajnish, Tekwani, Babu, Calderón, Angela I
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3828397/ https://www.ncbi.nlm.nih.gov/pubmed/24209891 http://dx.doi.org/10.1186/1752-153X-7-175

Ejemplares similares

Plasmodium falciparum Thioredoxin Reductase (PfTrxR) and Its Role as a Target for New Antimalarial Discovery
por: McCarty, Sara E., et al.
Publicado: (2015)

Preliminary LC-MS Based Screening for Inhibitors of Plasmodium falciparum Thioredoxin Reductase (PfTrxR) among a Set of Antimalarials from the Malaria Box
por: Tiwari, Neil K., et al.
Publicado: (2016)

A Parasite Rescue and Transformation Assay for Antileishmanial Screening Against Intracellular Leishmania donovani Amastigotes in THP1 Human Acute Monocytic Leukemia Cell Line
por: Jain, Surendra K., et al.
Publicado: (2012)

In vitro and in vivo anti-malarial activity of tigecycline, a glycylcycline antibiotic, in combination with chloroquine
por: Sahu, Rajnish, et al.
Publicado: (2014)

Discovery of Small-Molecule Allosteric Inhibitors of PfATC as Antimalarials
por: Wang, Chao, et al.
Publicado: (2022)

Genetic validation of PfFKBP35 as an antimalarial drug target
por: Thommen, Basil T, et al.
Publicado: (2023)

Inhibitors of ubiquitin E3 ligase as potential new antimalarial drug leads
por: Jain, Jagrati, et al.
Publicado: (2017)

Orthosteric–allosteric dual inhibitors of PfHT1 as selective antimalarial agents
por: Huang, Jian, et al.
Publicado: (2021)

In Silico Mining for Antimalarial Structure-Activity Knowledge and Discovery of Novel Antimalarial Curcuminoids
por: Viira, Birgit, et al.
Publicado: (2016)

Optimization of 2,3-Dihydroquinazolinone-3-carboxamides as Antimalarials Targeting PfATP4
por: Ashton, Trent D., et al.
Publicado: (2023)

Identification and Functional Validation of the Novel Antimalarial Resistance Locus PF10_0355 in Plasmodium falciparum
por: Van Tyne, Daria, et al.
Publicado: (2011)

Combined Transcriptome and Proteome Profiling for Role of pfEMP1 in Antimalarial Mechanism of Action of Dihydroartemisinin
por: Chen, Lina, et al.
Publicado: (2021)

Role of quassinoids as potential antimalarial agents: An in silico approach
por: Rampogu, Shailima
Publicado: (2015)

Development of Potent PfCLK3 Inhibitors Based on TCMDC-135051 as a New Class of Antimalarials
por: Mahindra, Amit, et al.
Publicado: (2020)

TIGAR knockdown radiosensitizes TrxR1-overexpressing glioma in vitro and in vivo via inhibiting Trx1 nuclear transport
por: Zhang, Yushuo, et al.
Publicado: (2017)

Antimalarials and Phytotoxins from Botryosphaeria dothidea Identified from a Seed of Diseased Torreya taxifolia
por: Kumarihamy, Mallika, et al.
Publicado: (2020)

Current Perspectives on Diagnostic Assays and Anti-PF4 Antibodies for the Diagnosis of Heparin-Induced Thrombocytopenia
por: Sahu, Kamal K, et al.
Publicado: (2020)

In Vitro and In Silico Characterization of an Antimalarial Compound with Antitumor Activity Targeting Human DNA Topoisomerase IB
por: Soren, Bini Chhetri, et al.
Publicado: (2021)

Substrate-analogous inhibitors exert antimalarial action by targeting the Plasmodium lactate transporter PfFNT at nanomolar scale
por: Golldack, André, et al.
Publicado: (2017)

Emerging Southeast Asian PfCRT mutations confer Plasmodium falciparum resistance to the first-line antimalarial piperaquine
por: Ross, Leila S., et al.
Publicado: (2018)

Intrinsic flexibility of B-DNA: the experimental TRX scale
por: Heddi, Brahim, et al.
Publicado: (2010)

The VMOD-TRX: A device for communicating with remote instrumentation
por: Barreira Sevillano, A, et al.
Publicado: (1996)

To inhibit TrxR1 is to inactivate STAT3–Inhibition of TrxR1 enzymatic function by STAT3 small molecule inhibitors
por: Busker, Sander, et al.
Publicado: (2020)

Na(+) Regulation in the Malaria Parasite Plasmodiumfalciparum Involves the Cation ATPase PfATP4 and Is a Target of the Spiroindolone Antimalarials
por: Spillman, Natalie J., et al.
Publicado: (2013)

Identification of PLX4032-resistance mechanisms and implications for novel RAF inhibitors
por: Choi, Jaehyuk, et al.
Publicado: (2014)

Investigations on Anticancer and Antimalarial Activities of Indole-Sulfonamide Derivatives and In Silico Studies
por: Pingaew, Ratchanok, et al.
Publicado: (2021)

Characterization of TrxC, an Atypical Thioredoxin Exclusively Present in Cyanobacteria
por: López-Maury, Luis, et al.
Publicado: (2018)

β-Sitosterol targets Trx/Trx1 reductase to induce apoptosis in A549 cells via ROS mediated mitochondrial dysregulation and p53 activation
por: Rajavel, Tamilselvam, et al.
Publicado: (2018)

The malaria parasite cation ATPase PfATP4 and its role in the mechanism of action of a new arsenal of antimalarial drugs
por: Spillman, Natalie Jane, et al.
Publicado: (2015)

Mutations in the P-Type Cation-Transporter ATPase 4, PfATP4, Mediate Resistance to Both Aminopyrazole and Spiroindolone Antimalarials
por: Flannery, Erika L., et al.
Publicado: (2014)

Mechanism of artemisinin resistance for malaria PfATP6 L263 mutations and discovering potential antimalarials: An integrated computational approach
por: N., Nagasundaram, et al.
Publicado: (2016)

A tetraoxane-based antimalarial drug candidate that overcomes PfK13-C580Y dependent artemisinin resistance
por: O'Neill, Paul M., et al.
Publicado: (2017)

Mutant PfCRT Can Mediate Piperaquine Resistance in African Plasmodium falciparum With Reduced Fitness and Increased Susceptibility to Other Antimalarials
por: Wicht, Kathryn J, et al.
Publicado: (2022)

In Vitro and In Silico Antimalarial Evaluation of FM-AZ, a New Artemisinin Derivative
por: Tsamesidis, Ioannis, et al.
Publicado: (2022)

In Silico and In Vitro Antimalarial Screening and Validation Targeting Plasmodium falciparum Plasmepsin V
por: Ji, Xin, et al.
Publicado: (2022)

Application of Ionic Liquids in Pot-in-Pot Reactions
por: Çınar, Simge, et al.
Publicado: (2016)

Next-Generation Human Liver Models for Antimalarial Drug Assays
por: Kulkeaw, Kasem
Publicado: (2021)

Disruption of a Plasmodium falciparum Multidrug Resistance-associated Protein (PfMRP) Alters Its Fitness and Transport of Antimalarial Drugs and Glutathione
por: Raj, Dipak Kumar, et al.
Publicado: (2009)

Antiplasmodial and Cytotoxic Cytochalasins from an Endophytic Fungus, Nemania sp. UM10M, Isolated from a Diseased Torreya taxifolia Leaf
por: Kumarihamy, Mallika, et al.
Publicado: (2019)

The Role of NOX4 and TRX2 in Angiogenesis and Their Potential Cross-Talk
por: Chen, Chaofei, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_570pd91aoj4fb3bsfidg1pm257